Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
STRO-002 is an antibody-drug conjugate that consists of an anti-FolRa human IgG1 antibody linked to the anti-tubulin agent 3-aminophenyl hemiasterlin (SC209), which may inhibit growth of FolRa expressing tumors (Cancer Res 2018;78(13 Suppl):Abstract nr 1782).
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|Bevacizumab + STRO-002||Bevacizumab STRO-002||0||1|